Beijing Delhi Trading Import and Export Company

Tarceva can relieve the pain of most patients. Anti-cancer treatment may relieve cancer pain, but it cannot relieve the pain of all cancer patients. The low consumption of medical opiates and the unreasonable medication structure reflect that the problem of cancer pain treatment in my country remains unresolved.
Global medical opioid consumption has skyrocketed in recent years, but most opioid analgesics are consumed in North America and Europe with limited populations, while China and other developing countries only account for 10% of the world's total medical opioid consumption. For patients with cancer pain, it is necessary to provide active analgesic treatment at the same time as Tarceva’s anti-tumor treatment in India. The most important reason is the fear of addiction caused by insufficient knowledge. In 2016, the World Health Organization announced the three-way analgesic principle for cancer. For mild pain and little impact on daily life and work, non-opioid analgesics, such as non-steroidal antipyretic analgesics, are given for pain relief for moderate pain. , will affect sleep and require the use of weak opioid analgesics for severe pain, it is recommended to use strong opioids.
The obstacles come from three aspects: medical personnel, Indian Tarceva supply and management, and the public. Cancer pain patients probably suffer from severe pain. If patients with moderate pain are included, there will be even more patients who need special attention and analgesic treatment. Patients and family members should also actively communicate with doctors and strive for reasonable analgesic treatment to improve the patient's quality of life. Therefore, we advocate that every suffering cancer patient should receive the most basic analgesic treatment. Relevant documents issued by the World Health Organization point out that although there are various treatment methods for cancer pain, opioid analgesics are indispensable and have an irreplaceable status. The latter two categories are prescription drugs and must be used strictly in accordance with doctor's instructions. Cancer pain may occur at different stages, and ~90% of patients with advanced cancer will experience cancer pain. Medical morphine consumption equivalents often reflect the level of analgesic treatment in a country. After years of promotion, we have made improvements, but we still cannot meet the needs of patients. According to estimates, approximately 10% of cancer patients in my country do not receive basic analgesic treatment. I have been doing clinical work for cancer pain relief for many years, and I have not had a single patient become addicted. For advanced patients who cannot accept traumatic and toxic treatments, pain relief may be the only treatment they can benefit from and tolerate.
In the late 1990s, cancer treatment in China was severely inadequate. Our annual consumption of opioid analgesics only accounted for 15% of the world's total, and our population was far from the actual demand.
There are approximately 10,000 new cancer cases in China every year. In fact, the research and development of analgesic drugs has been greatly improved in recent years. Opioids will not become addictive if they are used in a standardized and reasonable manner under the guidance of a doctor. Rough statistics show that there are approximately 10,000 cancer pain patients across the country suffering from cancer every day. There are also many patients who have cancer pain before their condition worsens, because Tarceva anti-cancer treatment in India may also cause pain, such as scar adhesion after surgery. Two to three hundred years ago, opium harmed the Chinese people, causing disastrous changes and years of psychological shadow.